---
figid: PMC6274686__ijms-19-03419-g006
figtitle: NOD1 signaling cascade
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
- Danio rerio
pmcid: PMC6274686
filename: ijms-19-03419-g006.jpg
figlink: /pmc/articles/PMC6274686/figure/ijms-19-03419-f006/
number: F6
caption: Model of NOD1 signaling cascade. Nucleotide-binding oligomerization domain
  1 (NOD1) characterized by three motifs containing a C-terminal leucine-rich repeat
  (LRR) domain, a central nucleotide-binding domain (NBD), and a variable N-terminal
  caspase recruitment domains (CARD), which could be activated by γ-D-Glu-mDAP (IE-DAP).
  NOD1 recruits the adaptor RIP2 and facilitates recruitment of TAK1 and NEMO. Here
  the TAK1 recruits TAB1 and TAB2/3 inducing MAPK activation. In addition, NEMO instigates
  activation of NF-κB by reducing IκBα and phosphorylating P65, the subunit of NF-κB.
  Furthermore, activation of MAPK and NF-κB promotes the cell cycle and proliferation.
  In our study, Evodiamine could potentially suppress the NOD1 signal pathway to inhibit
  the cell cycle and proliferation. The arrows represents the activation and the T
  bar represents the suppression.
papertitle: Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing
  NOD1 Signal Pathway.
reftext: Xing-Xian Guo, et al. Int J Mol Sci. 2018 Nov;19(11):3419.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9602057
figid_alias: PMC6274686__F6
figtype: Figure
redirect_from: /figures/PMC6274686__F6
ndex: 087cb36d-dedd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6274686__ijms-19-03419-g006.html
  '@type': Dataset
  description: Model of NOD1 signaling cascade. Nucleotide-binding oligomerization
    domain 1 (NOD1) characterized by three motifs containing a C-terminal leucine-rich
    repeat (LRR) domain, a central nucleotide-binding domain (NBD), and a variable
    N-terminal caspase recruitment domains (CARD), which could be activated by γ-D-Glu-mDAP
    (IE-DAP). NOD1 recruits the adaptor RIP2 and facilitates recruitment of TAK1 and
    NEMO. Here the TAK1 recruits TAB1 and TAB2/3 inducing MAPK activation. In addition,
    NEMO instigates activation of NF-κB by reducing IκBα and phosphorylating P65,
    the subunit of NF-κB. Furthermore, activation of MAPK and NF-κB promotes the cell
    cycle and proliferation. In our study, Evodiamine could potentially suppress the
    NOD1 signal pathway to inhibit the cell cycle and proliferation. The arrows represents
    the activation and the T bar represents the suppression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tab2
  - nmo
  - IKKepsilon
  - key
  - IKKbeta
  - bsk
  - dl
  - wash
  - Dif
  - Rel
  - Erk7
  - rl
  - Hrb27C
  - betaTub60D
  - Rpt5
  - DCTN2-p50
  - MKP-4
  - p38b
  - CycE
  - cyc
  - lic
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - RIPK2
  - ARHGEF28
  - TAB2
  - IKBKG
  - CHUK
  - IKBKB
  - IKBKE
  - TBK1
  - MAPK8
  - MAPK9
  - MAPK10
  - NFKBIA
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - NFKB1
  - EPHB2
  - MAPK1
  - MAPK3
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - CRK
  - GRAP2
  - AHSA1
  - POLDIP2
  - tab2
  - ikbkg
  - mapk8b
  - rela
  - nfkb1
  - mapk14a
  - Evodiamine
---
